Related Experiment Videos

[Treatment with Pharmachim's Chlophazolin of hypertension and symptomatic hypertonia]

Vutreshni Bolesti
|January 1, 1986
PubMed

Insights

Chlophazolin effectively managed arterial hypertension in 127 patients, showing satisfactory results with minimal side effects. This hypertension treatment proved safe and well-tolerated, with only mild adverse effects like dry mouth reported.

Area of Science:

  • Pharmacology
  • Cardiology
  • Internal Medicine

Background:

  • Arterial hypertension is a significant global health concern.
  • Effective and safe antihypertensive medications are crucial for patient management.

Purpose of the Study:

  • To evaluate the efficacy and safety of chlophazolin in treating patients with arterial hypertension.
  • To assess the drug's impact on clinical symptoms and blood pressure levels.

Main Methods:

  • A one-year study involving 127 patients with arterial hypertension (symptomatic and essential).
  • Chlophazolin was administered as monotherapy or in combination with other antihypertensive drugs.
  • Efficacy was assessed by clinical symptoms and blood pressure monitoring. Safety was evaluated through adverse event reporting.

Main Results:

  • Satisfactory control of clinical symptoms and blood pressure was achieved in all treated patients.
  • Diuretics and beta-blockers were infrequently required as adjunct therapy for enhanced effect.
  • No toxic or allergic reactions were observed; dry mouth and sleepiness were the most frequent adverse effects.

Conclusions:

  • Chlophazolin demonstrates significant efficacy in managing arterial hypertension.
  • The drug is well-tolerated, with a favorable safety profile and minimal adverse effects.
  • Chlophazolin represents a valuable therapeutic option for arterial hypertension management.

Related Concept Videos